基因组学与应用生物学

参考文献

陈茗莉，郑群，马芳芳，等，2022.4种血清因子预测冠状动脉粥样硬化性心脏病发病的价值.中华高血压杂志，30(11):1080-1084.[CHEN M L,ZHENG Q,MA F F,et al.,2022.The value of 4 serum factors in predicting the development of coronary atherosclerotic heart disease.Chinese Journal of Hypertension,30(11):1080-1084.]

高雪婷，陈小美，2023.白介素6检测在心血管疾病诊断中的价值探析.文摘版：医药卫生，(10):78-80.[GAO X T,CHEN X M,2023.Exploring the value of interleukin 6 testing in the diagnosis of cardiovascular disease.Digest Version:Medicine and Hygiene,(10):78-80.]

胡丰林，2022.RBP4、 hs-CRP、 IL-6水平检测在冠心病病情评估中的应用.中国民康医学，34(7):126-129.[HU F L,2022.Application of RBP4,hs-CRP and IL-6 level detection in assessment of coronary heart disease.Medical Journal of Chinese People′s Health,34(7):126-129.]

滑世轩，代淑阳，李冰洁，等，2023.血脂正常冠心病患者炎症因子水平与病情严重程度的关系.检验医学，38(31):66-68.[HUA S X,DAI S Y,LI B J,et al.,2023.The relationship between the levels of inflammatory factors and the severity of coronary heart disease in patients with normal blood lipids.Laboratory Medicine,38(31):66-68.]

黄达，潘兴寿，邹才华，等，2023.冠心病患者血清TLR4水平增高及其与TLR4基因突变和临床的关系的研究.亚洲心脑血管病例研究，11(2):9-16.[HUANG D,PAN X S,ZOU C H,et al.,2023.Study on the Relationship between the Increased Serum TLR4 Level and TLR4 Gene Mutation and Clinic in Patients with Coronary Heart Disease.Asian Case Reports in Vascular Medicine,11(2):9-16.]

黄珊，吴海科，黄强，等，2023.载脂蛋白E基因多态性分布与心脑血管疾病发生风险的相关性.国际检验医学杂志，44(14):1723-1726.[HUANG S,WU H K,HUANG Q,et al.,2023.Correlation between apolipoprotein E gene polymorphism and cardiovascular and cerebrovascular diseases.International Journal of Laboratory Medicine,44(14):1723-1726.]

黄宇翔，苟志平，张丽丽，等，2022.瘦素通过FAK/Src途径对心肌梗死大鼠心功能及心室重构的作用研究.实用药物与临床，25(8):678-684.[HUANG Y X,GOU Z P,ZHANG L L,et al.,2022.Study on the effect of leptin on cardiac function and ventricular remodeling in rats with myocardial infarction through FAK/Src pathway.Practical Pharmacy and Clinical Remedies,25(8):678-684.]

李家英，蔡艳，杨慰，等，2023.血清TNF-α、 IL-6、 hs-CRP在冠心病患者中的表达水平及临床意义.分子诊断与治疗杂志，15(6):943-946,950.[LI J Y,CAI Y,YANG W,et al.,2023.Expression levels and clinical significance of serum TNF-α,IL-6,hs-CRP in patients with coronary heart disease.Journal of Molecular Diagnostics and Therapy,15(6):943-946,950.]

聂晓丹，崔赛赛，孙博，等，2022.冠状动脉粥样硬化性心脏病危险因素分析.创伤与急危重病医学，10(1):68-70.[NIE X D,CUI S S,SUN B,et al.,2022.Analysis of risk factors for coronary atherosclerotic heart disease.Trauma and Critical Care Medicine,10(1):68-70.]

仇晨光，丁龙坤，孙洪涛，等，2023.冠状动脉粥样硬化性心脏病患者血清炎症指标与血脂水平相关性的研究.临床医学进展，13(3):3528-3533.[QIU C G,DING L K,SUN H T,et al.,2023.Study on the correlation between serum inflammatory markers and lipid levels in patients with coronary heart disease.Advances in Clinical Medicine,13(3):3528-3533.]

邱微，俞勤凯，2023.H型高血压伴冠心病患者Hcy、 MMP-9和瘦素水平变化及相关性分析.河北医药，45(2):263-265.[QIU W,YU Q K,2023.Changes of Hcy,MMP-9 and leptin levels in H-type hypertension patients with coronary heart disease and its correlation analysis.Hebei Medical Journal,45(2):263-265.]

任晓宇，周白丽，2023.脂蛋白a、 载脂蛋白B在冠状动脉粥样硬化性心脏病诊治中的应用进展.中国医学创新，20(13):169-173.[REN X Y,ZHOU B L,2023.Application progress of lipoprotein a and apolipoprotein B in the diagnosis and treatment of coronary atherosclerotic heart disease.Medical Innovation of China,20(13):169-173.]

王德芳，黄水英，林强，等，2022.心周脂肪体积联合脂蛋白α、 载脂蛋白B可诊断早期冠心病：基于MSCT测量.分子影像学杂志，45(6):867-870.[WANG D F,HUANG S Y,LIN Q,et al.,2022.Early diagnostic efficiency of coronary heart disease based on multi-slice spiral CT measurement of pericardial fat volume combined with lipoprotein α and apolipoprotein B detection.Journal of Molecular Imaging,45(6):867-870.]

王念鸿，聂庆东，李英姿，等，2019.肿瘤坏死因子α与糖尿病肾病病理分期、 心血管事件的关系.实用医学杂志，35(2):261-265.[WANG N H,NIE Q D,LI Y Z,et al.,2019.Study on the relationship between tumor necrosis factor-α and pathological stage of diabetic nephropathy and cardiovascular events.The Journal of Practical Medicine,35(2):261-265.]

王艳，袁艺，淡雪川，2020.载脂蛋白B编码基因突变与冠心病发病风险及传统危险因素交互作用.西部医学，32(10):1542-1546.[WANG Y,YUAN Y,DAN X C,2020.Study on the interaction between apolipoprotein B gene mutation and coronary heart disease risk and traditional risk factors.Medical Journal of West China,32(10):1542-1546.]

吴安东，刘建坤，赵雅，等，2022.冠心病的遗传机制.中国科学：生命科学，52(2):123-137.[WU A D,LIU J K,ZHAO Y,et al.,2022.Genetics of coronary artery disease.Scientia Sinica(Vitae),52(2):123-137.]

肖懿慧，舒娟，袁祖贻，等，2021.陕西地区心血管疾病患者ApoE基因多态性分布及其与血脂水平和冠心病类型的相关性.西安交通大学学报：医学版，42(3):398-401.[XIAO Y H,SHU J,YUAN Z Y,et al.,2021.Distribution of ApoE polymorphism and its correlation with blood lipid level and type of coronary heart disease in Shaanxi.Journal of Xi′an Jiaotong University(Medical Sciences),42(3):398-401.]

熊燕华，米蓁，彭及雅，等，2023.基线非传统血脂指标对冠状动脉粥样硬化病变风险的预测价值.中国循证心血管医学杂志，15(5):558-564.[XIONG Y H,MI Z,PENG J Y,et al.,2023.The predictive values of baseline fasting non-traditional lipid indexes for the severity and morbidity of coronary heart disease.Chinese Journal of Evidence-Based Cardiovascular Medicine,15(5):558-564.]

徐阳，韩拓，刘莉君，等，2023.ApoE基因多态性与糖脂代谢及动脉硬化关联性分析.临床血液学杂志，36(6):393-397.[XU Y,HAN T,LIU L J,et al.,2023.Association analysis of ApoE gene polymorphism with glucolipid metabolism and arteriosclerosis.Journal of Clinical Hematology,36(6):393-397.]

杨立，陈葳，2021.载脂蛋白E基因多态性对冠心病患者血脂水平的影响研究.现代医药卫生，37(21):3649-3651.[YANG L,CHEN W,2021.Effect of apolipoprotein E gene polymorphism on blood lipid level in patients with coronary heart disease.Journal of Modern Medicine & Health,37(21):3649-3651.]

药红梅，庞永强，陈钰彬，等，2022.白细胞介素-6基因多态性与冠心病风险的关系探讨.中西医结合心脑血管病杂志，20(14):2512-2516.[YAO H M,PANG Y Q,CHEN Y B,et al.,2022.Association between interleukin-6 polymorphisms and risk of coronary artery diseases.Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease,20(14):2512-2516.]

余淼，杨芬，程翔，2021.冠心病的抗炎治疗：路在何方?.中华心血管病杂志，49(2):111-114.[YU M,YANG F,CHENG X,2021.Anti-inflammatory therapy of coronary heart disease:where is the way?.Chinese Journal of Cardio-logy,49(2):111-114.]

赵真真，马云霞，2023.细胞焦亡相关因子表达对2型糖尿病患者动脉粥样硬化性心血管病的预测作用.中国卫生检验杂志，33(3):323-326.[ZHAO Z Z,MA Y X,2023.Predictive value of cell pyrophosis related factor expression on atherosclerotic cardiovascular disease in patients with type 2 diabetes.Chinese Journal of Health Laboratory Technology,33(3):323-326.]

中国心血管健康与疾病报告编写组，2023.中国心血管健康与疾病报告2022概要.中国循环杂志，38(6):583-612.[The Writing Committee of the Report on cardiovascular health and diseases in China,2023.Report on Cardiovascular Health and Diseases in China 2022:an updated summary.Chinese Circulation Journal,38(6):583-612.]

中国医师协会中西医结合分会心血管专业委员会，中华中医药学会心血管病分会，安冬青，等，2022.动脉粥样硬化中西医防治专家共识(2021年).中国中西医结合杂志，42(3):287-293.[CMDA,CACM,AN D Q,et al.,2022.Experts consensus on prevention and treatment of atherosclerosis by integrative medicine(2021).Chinese Journal of Integrated Traditional and Western Medicine,42(3):287-293.]

周正雅，柴玉琼，袁晶，等，2023.成人血尿酸水平与冠状动脉粥样硬化性心脏病的关联分析.公共卫生与预防医学，34(1):141-143.[ZHOU Z Y,CHAI Y Q,YUAN J,et al.,2023.Relationship between uric acid and coronary atherosclerotic heart disease in adults.Journal of Public Health and Preventive Medicine,34(1):141-143.]

ALAGARSAMY J,JAESCHKE A,HUI D Y,2022.Apolipoprotein E in cardiometabolic and neurological health and diseases.Int.J.Mol.Sci.,23(17):9892.

CLARKE R,VON ENDE A,SCHMIDT L E,et al.,2023.Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease.Circ.Res.,132(4):452-464.

COTO E,LORCA R,RODRíGUEZ-REGUERO J,et al.,2021.The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease:data from a Spanish cohort.Nutr.Metab.Cardiovasc.Dis.,31(5):1564-1568.

DIDICHENKO S A,VELKOSKA E,NAVDAEV A V,et al.,2023.CSL112 infusion rapidly increases APOA1 exchange rate via specific serum amyloid-poor HDL subpopulations when administered to patients post-myocardial infarction.Arterioscler.Thromb.Vasc.Biol.,43(6):855-869.

EI HADRI K,SMITH R,DUPLUS E,et al.,2021.Inflammation,oxidative stress,senescence in atherosclerosis:thioredoxine-1 as an emerging therapeutic target.Int.J.Mol.Sci.,23(1):77.

IBI D,BOOT M,DOLLé M E T,et al.,2022.Apolipoprotein A-V is a potential target for treating coronary artery disease:evidence from genetic and metabolomic analyses.J.Lipid Res.,63(5):100193.

KATTA N,LOETHEN T,LAVIE C J,et al.,2021.Obesity and coronary heart disease:epidemiology,pathology,and coronary artery imaging.Curr.Probl.Cardiol.,46(3):100655.

KHAKI-KHATIBI F,SHADEMAN B,GHOLIKHANI-DARBROUD R,et al.,2022.Gene polymorphism of leptin and risk for heart disease,obesity,and high BMI:a systematic review and pooled analysis in adult obese subjects.Horm.Mol.Biol.Clin.Investig.,44(1):11-20.

LUO C Y,POOK E,TANG B,et al.,2017b.Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription.Biochim.Biophys.Acta Mol.Basis Dis.,1863(9):2319-2332.

LUO C Y,POOK E,WANG F,et al.,2020.ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease.Gene,753:144805.

LUO C Y,TANG B,QIN S B,et al.,2021b.GATA2 regulates the CAD susceptibility gene ADTRP rs6903956 through preferential interaction with the G allele.Mol.Genet.Genomics,296(4):799-808.

LUO C Y,WANG D C,HUANG W F,et al.,2021a.Feedback regulation of coronary artery disease susceptibility gene ADTRP and LDL receptors LDLR/CD36/LOX-1 in endothelia cell functions involved in atherosclerosis.Biochim.Biophys.Acta Mol.Basis Dis.,1867(7):166130.

LUO C Y,WANG F,REN X,et al.,2017a.Identification of a molecular signaling gene-gene regulatory network between GWAS susceptibility genes ADTRP and MIA3/TANGO1 for coronary artery disease.Biochim.Biophys.Acta Mol.Basis Dis.,1863(6):1640-1653.

MA J L,GU Y Y,LIU J J,et al.,2022.Functional screening of congenital heart disease risk loci identifies 5 genes essential for heart development in zebrafish.Cell.Mol.Life Sci.,80(1):19.

MARSTON N A,GIUGLIANO R P,MELLONI G E M,et al.,2022.Association of apolipoprotein B-containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis:distinguishing between particle concentration,type,and content.JAMA Cardiol.,7(3):250-256.

MORJANE I,CHAROUTE H,OUATOU S,et al.,2020.Association of c.56C > G (rs3135506) apolipoprotein A5 gene polymorphism with coronary artery disease in Moroccan subjects:a case-control study and an updated meta-analysis.Cardiol.Res.Pract.,2020:5981971.

OOI D S Q,ONG S M,ENG M H,et al.,2020.Detection of ADTRP in circulation and its role as a novel biomarker for coronary artery disease.PLoS ONE,15(8):e0237074.

ORECCHIONI M,KOBIYAMA K,WINKELS H,et al.,2022.Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production.Science,375(6577):214-221.

P?UNIC? I,MIHAI A D,TEFAN S,et al.,2023.Comparative evaluation of LDL-CT,non-HDL/HDL ratio,and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus.J.Diabetes Complications,37(12):108634.

ROY A,SAQIB U,BAIG M S,2021.NOS1-mediated macrophage and endothelial cell interaction in the progression of atherosclerosis.Cell Biol.Int.,45(6):1191-1201.

SCHWAIGER J P,KOLLERITS B,STEINBRENNER I,et al.,2022.Apolipoprotein A-Ⅳ concentrations and clinical outcomes in a large chronic kidney disease cohort:results from the GCKD study.J.Intern.Med.,291(5):622-636.

SOEHNLEIN O,LIBBY P,2021.Targeting inflammation in atherosclerosis-from experimental insights to the clinic.Nat.Rev.Drug Discov.,20(8):589-610.

SU L,MITTAL R,RAMGOBIN D,et al.,2021.Current mana-gement guidelines on hyperlipidemia:the silent killer.J.Lipds.,2021:9883352.

ULLOQUE-BADARACCO J R,AL-KASSAB-CóRDOVA A,HERNANDEZ-BUSTAMANTE E A,et al.,2023.Association of apolipoproteins and lipoprotein(a) with metabolic syndrome:a systematic review and meta-analysis.Lipids Health Dis.,22(1):98.

WANG F,XU C Q,HE Q,et al.,2011.Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population.Nat.Genet.,43(4):345-349.

WANG H D,WANG C,HAN W X,et al.,2020.Association of leptin and leptin receptor polymorphisms with coronary artery disease in a North Chinese Han population.Rev.Da Sociedade Bras.De Med.Trop.,53:e20190388.

WU Y,WANG L,ZHAN Y,et al.,2022.The expression of SAH,IL-1β,Hcy,TNF-α and BDNF in coronary heart disease and its relationship with the severity of coronary stenosis.BMC Cardiovasc.Disord.,22(1):101.

WU Y,ZHAO F J,SURE V N,et al.,2023.Human ApoE2 endows stronger contractility in rat cardiomyocytes enhancing heart function.Cells,12(3):347.

XU J W,ZHENG Y B,ZHAO Y Q,et al.,2022.Succinate/IL-1β signaling axis promotes the inflammatory progression of endothelial and exacerbates atherosclerosis.Front.Immunol.,13:817572.

XUE H,FAN L X,LIU C,2023.Associations of ApoE polymorphisms with postoperative atrial fibrillation and cardiac injury in patients with coronary artery bypass graft surgery.Int.Heart J.,64(6):1049-1053.

YOU L,2023.Relationship between dynamic electrocardiogram and CRP,IL-6,ET-1 expression in myocardial ischemia patients with coronary heart disease.Cell.Mol.Biol.,69(12):52-56.

ZUSI C,CSERMELY A,RINALDI E,et al.,2023.Crosstalk between genetic variability of adiponectin and leptin,glucose-insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes.The Verona Newly Diagnosed Type 2 Diabetes Study 14.Diabetes Obes.Metab.,25(9):2650-2658.